Efficacy and Safety of Antiplatelet Agents for Adult Patients With Ischemic Moyamoya Disease
Fei Ye(Army Medical University), Wenli Sheng(Sun Yat-sen University), Xiaoxin Wu(First Affiliated Hospital Zhejiang University), Kai Lan(Army Medical University), Tingting Yang(Southern Taiwan Science Park), Jiaoxing Li(Sun Yat-sen University), Qi Li(Qingdao National Laboratory for Marine Science and Technology), Haiyan Li(Sun Yat-sen University), Xiong Zhang(Dalian Medical University), Jie Liang(Sun Yat-sen University), Tongli Guo(Guiyang Medical University), Tianzhu Wang(The Affiliated Yongchuan Hospital of Chongqing Medical University), Haoyuan Yin(Jilin University)
Cited by 29
Related Papers
Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19)
|Clinical Infectious Diseases|2020|556
Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study
|Translational Psychiatry|2018|231
The receptor tyrosine kinase inhibitor SU11248 impedes endothelial cell migration, tubule formation, and blood vessel formation in vivo, but has little effect on existing tumor vessels
|Angiogenesis|2004|154
Myosin Ib modulates the morphology and the protein transport within multi-vesicular sorting endosomes
|Journal of Cell Science|2005|94